BioLife Solutions, Inc. (BLFS)

BioLife Solutions Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	24	33.04	91.54	27.9	19.44	69.86
Short-Term Investments	58.42	55.89	9.2	16.29	43.26	-
Cash & Short-Term Investments	82.42	88.93	100.74	44.18	62.7	69.86
Cash Growth	0.80%	-11.72%	127.99%	-29.53%	-10.25%	-22.72%
Receivables	10.65	7.95	8.48	7.9	33.94	23.22
Inventory	35.59	30.16	29.01	27.16	34.9	28.35
Prepaid Expenses	6.54	9.53	5.95	4.67	6.88	4.66
Restricted Cash	-	-	-	-	0.03	0.01
Other Current Assets	-	-	4.58	36.69	-	-
Total Current Assets	135.2	136.56	148.76	120.6	138.45	126.09
Property, Plant & Equipment	23.88	22.18	16.53	19.48	48.27	46.61
Long-Term Investments	30.65	31.25	5.62	5.62	6.4	4.37
Goodwill	208.59	208.59	208.59	212.3	224.74	224.74
Other Intangible Assets	3.65	4.26	5.57	12	32.09	152.15
Other Long-Term Assets	0.31	3.05	14.42	42.71	0.28	0.33
Total Assets	447.49	405.88	399.49	412.71	450.23	554.29

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.48	1.49	3.36	2.27	15.37	14.95
Accrued Expenses	8.68	14.06	16.25	13.22	12.36	8.6
Current Portion of Long-Term Debt	-	5	10.94	6.29	1.81	0.86
Current Portion of Leases	2.59	2.24	1.46	1.29	3.02	2.91
Current Income Taxes Payable	-	-	-	0.26	0.98	0.03
Current Unearned Revenue	0.19	0.2	0.1	0.04	0.55	0.81
Other Current Liabilities	-	-	0.62	18.82	10.5	14.55
Total Current Liabilities	13.95	22.98	32.73	42.18	44.58	42.7
Long-Term Debt	-	-	5	17.56	23.79	6.35
Long-Term Leases	13.15	10.66	12.65	8.7	15.09	16.76
Long-Term Deferred Tax Liabilities	-	0.19	0.12	0.11	0.25	5.49
Other Long-Term Liabilities	0.4	0.17	0.08	6.5	2.33	4.94
Total Liabilities	27.49	34	50.58	75.05	86.04	76.24

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.05	0.05	0.05	0.05	0.04	0.04
Additional Paid-In Capital	713.57	711.4	683.94	652.88	611.74	585.4
Retained Earnings	-293.41	-339.7	-335.1	-314.92	-246.92	-107.11
Comprehensive Income & Other	-0.21	0.13	0.02	-0.35	-0.68	-0.28
Total Common Equity	420	371.89	348.91	337.66	364.19	478.05
Shareholders' Equity	420	371.89	348.91	337.66	364.19	478.05
Total Liabilities & Equity	447.49	405.88	399.49	412.71	450.23	554.29

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	15.74	17.9	30.04	33.83	43.71	26.88
Net Cash (Debt)	97.33	102.28	75.32	10.91	18.99	42.98
Net Cash Growth	27.36%	35.79%	590.69%	-42.57%	-55.82%	-45.77%
Net Cash Per Share	1.96	2.10	1.64	0.25	0.44	1.12
Filing Date Shares Outstanding	48.91	48.3	47	45.3	43.21	42.09
Total Common Shares Outstanding	48.89	48.2	46.91	45.17	42.83	41.82
Working Capital	121.25	113.58	116.03	78.43	93.87	83.39
Book Value Per Share	8.59	7.72	7.44	7.48	8.50	11.43
Tangible Book Value	207.76	159.04	134.76	113.36	107.36	101.16
Tangible Book Value Per Share	4.25	3.30	2.87	2.51	2.51	2.42
Machinery	5.35	4.87	4.19	13.8	30.14	24.18
Construction In Progress	8.39	11.27	2.42	5.16	6.75	4.42
Leasehold Improvements	7.27	3.51	3.53	3.5	5.25	3.84

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error